APA aipamena

Berghauser Pont, L. M., Spoor, J. K., Venkatesan, S., Swagemakers, S., Kloezeman, J. J., Dirven, C. M., . . . Leenstra, S. (2014). The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells. Genes Cancer.

Chicago Style aipamena

Berghauser Pont, Lotte M.E., Jochem K.H Spoor, Subramanian Venkatesan, Sigrid Swagemakers, Jenneke J. Kloezeman, Clemens M.F Dirven, Peter J. van der Spek, Martine L.M Lamfers, and Sieger Leenstra. "The Bcl-2 Inhibitor Obatoclax Overcomes Resistance to Histone Deacetylase Inhibitors SAHA and LBH589 As Radiosensitizers in Patient-derived Glioblastoma Stem-like Cells." Genes Cancer 2014.

MLA aipamena

Berghauser Pont, Lotte M.E., et al. "The Bcl-2 Inhibitor Obatoclax Overcomes Resistance to Histone Deacetylase Inhibitors SAHA and LBH589 As Radiosensitizers in Patient-derived Glioblastoma Stem-like Cells." Genes Cancer 2014.